Event JSON
{
"id": "d2f77449ef11291e4b76c422d79767aeb6b2ce79b84971b0ad74433561d6f26b",
"pubkey": "95ef648972f67639a24ffac69a10247f561c3d5e1c178d55dfeeac9d3407e168",
"created_at": 1749144079,
"kind": 1,
"tags": [
[
"t",
"semaglutide"
],
[
"t",
"metabolic"
],
[
"t",
"steatohepatitis"
],
[
"client",
"snort",
"31990:84de35e2584d2b144aae823c9ed0b0f3deda09648530b93d1a2a146d1dea9864:app-profile"
]
],
"content": "Phase 3 Trial of #Semaglutide in #Metabolic Dysfunction–Associated #Steatohepatitis\n\nhttps://2medical.news/2025/05/24/phase-3-trial-of-semaglutide-in-metabolic-dysfunction-associated-steatohepatitis/",
"sig": "17031f49f0253b4bef9d02ce39f7a168b3e0ed9bc51efb2d814bafbc53aa9546f705f9bb002792320a9c8c5baae539f46d458a5e57fdd6cf6609f9280fe58323"
}
